Related Experiment Video
Updated: Aug 14, 2026

Exploring the Potential of Mesenchymal Stem Cell Sheet on The Development of Hepatocellular Carcinoma In Vivo
Published on: September 11, 2018
Carcinoembryonic antigen-related cell adhesion molecule 1a-4L suppression of rat hepatocellular carcinomas
Nikia A Laurie1, Meghan M Comegys, Marie P Carreiro
1Division of Hematology and Oncology, Department of Medicine, Rhode Island Hospital/Brown University Medical School, Providence, Rhode Island 02903, USA.
Abstract:
Carcinoembryonic antigen (CEA)-related cell adhesion molecule 1 (CEACAM1) is a member of the CEA family of immunoglobulin-like adhesion molecules with two major splice variants, CEACAM1(a)-4L and CEACAM1(b)-4S, differing in the length of their COOH-terminal cytoplasmic tail. Both forms are down-regulated in prostate and liver carcinomas relative to normal tissues. We have previously shown in a nude mouse xenograft model that restoration of CEACAM1(a)-4L expression in human prostate carcinoma cells (PC-3) suppresses tumorigenicity, an effect observed with carcinomas from several other tissues but never established for hepatocellular carcinomas. In this report, we have examined the effect of CEACAM1(a)-4L on tumorigenicity of 1682A, a rat hepatocellular carcinoma that grows on the omentum when injected into the peritoneal cavity. Results show that restoration of CEACAM1(a)-4L expression at levels 13- and 0.45-fold compared with negative controls or normal hepatocytes, respectively, completely suppressed the formation of 1682A tumor nodules on the omentum at 3 weeks after injection. In contrast, 1682A cells infected with CEACAM1(b)-4S or an empty retroviral vector formed multiple clusters of tumor nodules. Although tumor nodules of 1682A cells positive and negative for CEACAM1(a)-4L did not display significant differences in histologic organization, aggregates formed in vitro by 1682A-L were smaller in size and displayed enlarged intercellular spaces relative to their 1682A-V counterparts. Restoration of CEACAM1(a)-4L expression did not elevate levels of apoptosis but seemed to cause an increase in the length of G1. This is the first demonstration of CEACAM1(a)-4L-induced tumor suppression in liver carcinomas using a quantifiable i.p. syngeneic transplantation model.
Insights
Restoring Carcinoembryonic antigen (CEA)-related cell adhesion molecule 1 (CEACAM1) expression suppressed liver cancer growth in a rat model. This finding offers new insights into CEACAM1
Area of Science:
- Oncology
- Molecular Biology
- Cell Adhesion Molecules
Background:
- Carcinoembryonic antigen (CEA)-related cell adhesion molecule 1 (CEACAM1) is downregulated in various carcinomas.
- CEACAM1 has two major splice variants: CEACAM1(a)-4L and CEACAM1(b)-4S.
- Previous studies showed CEACAM1(a)-4L suppresses tumorigenicity in prostate cancer models.
Purpose of the Study:
- To investigate the effect of CEACAM1(a)-4L on the tumorigenicity of rat hepatocellular carcinoma (1682A).
- To determine if CEACAM1(a)-4L exhibits tumor suppressive properties in liver cancer.
- To establish a quantifiable model for studying CEACAM1's role in liver tumorigenesis.
Main Methods:
- Restoration of CEACAM1(a)-4L expression in 1682A rat hepatocellular carcinoma cells.
- Intraperitoneal injection of modified 1682A cells into syngeneic rats.
- Evaluation of tumor nodule formation on the omentum at 3 weeks post-injection.
- Analysis of cellular aggregates formed in vitro and cell cycle progression.
Main Results:
- Restoration of CEACAM1(a)-4L completely suppressed the formation of 1682A tumor nodules.
- CEACAM1(b)-4S or empty vector-infected cells formed multiple tumor nodules.
- In vitro aggregates of CEACAM1(a)-4L-expressing cells were smaller with enlarged intercellular spaces.
- CEACAM1(a)-4L expression increased G1 phase length without elevating apoptosis.
Conclusions:
- CEACAM1(a)-4L demonstrates significant tumor suppressive effects in a rat model of hepatocellular carcinoma.
- This study provides the first evidence of CEACAM1(a)-4L-induced tumor suppression in liver cancer using a syngeneic transplantation model.
- CEACAM1(a)-4L may represent a potential therapeutic target for liver cancer treatment.
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025